Deborah E. Wiley, Chair of The Wiley Foundation, John Wiley & Sons, Inc. (NYSE: JWa & JWb) today awarded the 2013 Wiley Prize in Biomedical Sciences to Dr. Michael Young, Rockefeller University, Dr. Jeffrey Hall, Brandeis University (Emeritus), and Dr. Michael Rosbash, Brandeis University.
The three researchers received their award at Rockefeller University in New York City, where they were honored at a luncheon and then presented a lecture on their discovery of the molecular mechanisms governing circadian rhythms.
"I would like to congratulate Drs. Young, Rosbash and Hall for this well-deserved honor," said Wiley. "Their groundbreaking research on circadian rhythms has the potential to lead to more discoveries that could help many people who are suffering from very common maladies and disorders."
"I am extremely pleased to be able to recognize this outstanding achievement in the area of biomedical research."
Studies of the molecular basis for circadian rhythmicity began more than thirty years ago in the lab of Dr. Young at Rockefeller University and Drs. Hall and Rosbash at Brandeis. Over the past three decades, the work of the three men focused on the fruitfly Drosophila melanogaster, with their research showing that the fly's circadian clocks are formed through the actions of a small group of genes.
These discoveries also apply to humans and other mammals, and could ultimately lead to the development of drugs to treat sleep disorders and jet lag, plus conditions associated with employees who work non-traditional shifts.
There is also evidence that the effectiveness of many drugs (including chemotherapeutics), our ability to fight infection, our ability to repair damaged tissues, and the incidence of certain forms of cancer depend on the proper working of circadian clocks.
Expanded access to weight-loss drugs could save thousands of lives